<- Go Home
Aethlon Medical, Inc.
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.
Market Cap
$2.8M
Volume
112.6K
Cash and Equivalents
$7.0M
EBITDA
-$7.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$35.20
52 Week Low
$1.36
Dividend
N/A
Price / Book Value
0.31
Price / Earnings
-0.07
Price / Tangible Book Value
0.31
Enterprise Value
-$3.8M
Enterprise Value / EBITDA
0.58
Operating Income
-$7.3M
Return on Equity
208.60%
Return on Assets
-62.88
Cash and Short Term Investments
$7.0M
Debt
$417.5K
Equity
$6.7M
Revenue
N/A
Unlevered FCF
-$4.5M
Sector
Health Care Equipment and Supplies
Category
N/A